Urine bile acids relate to glucose control in patients with type 2 diabetes mellitus and a body mass index below 30 kg/m2.

Bile acids are important endocrine signalling molecules, modulating glucose homeostasis through activation of cell surface and nuclear receptors. Bile acid metabolism is altered in type 2 diabetes mellitus; however, whether this is of pathogenic consequence is not fully established. In this study ur...

Full description

Bibliographic Details
Main Authors: David R Taylor, Jamshid Alaghband-Zadeh, Gemma F Cross, Sohail Omar, Carel W le Roux, Royce P Vincent
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24736330/?tool=EBI
id doaj-c257b7fbbbf846e694c4cd20e0e45038
record_format Article
spelling doaj-c257b7fbbbf846e694c4cd20e0e450382021-03-03T20:14:47ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0194e9354010.1371/journal.pone.0093540Urine bile acids relate to glucose control in patients with type 2 diabetes mellitus and a body mass index below 30 kg/m2.David R TaylorJamshid Alaghband-ZadehGemma F CrossSohail OmarCarel W le RouxRoyce P VincentBile acids are important endocrine signalling molecules, modulating glucose homeostasis through activation of cell surface and nuclear receptors. Bile acid metabolism is altered in type 2 diabetes mellitus; however, whether this is of pathogenic consequence is not fully established. In this study urinary bile acid excretion in individuals with type 2 diabetes and matched healthy volunteers was assessed. Urinary bile acid excretion in type 2 diabetes patients was considered in the context of prevailing glycaemia and the patient body mass index. Urine bile acids were measured by liquid chromatography-tandem mass spectrometry, allowing individual quantification of 15 bile acid species. Urinary bile acid excretion in patients with type 2 diabetes who were normal weight (BMI 18.5-24.9 kg/m2) and overweight (BMI 25-29.9 kg/m2) were elevated compared to healthy normal weight volunteers, both p<0.0001. In obese (BMI ≥ 30 kg/m2) type 2 diabetes patients, urinary bile acid excretion was significantly lower than in the normal and overweight type 2 diabetes groups (both p<0.01). Total bile acid excretion positively correlated with HbA1c in normal (rs=0.85, p=<0.001) and overweight (rs=0.61, p=0.02) but not obese type 2 diabetes patients (rs=-0.08, p=0.73). The glycaemia-associated increases in urine bile acid excretion in normal weight and overweight type 2 diabetes seen in this study may represent compensatory increases in bile acid signalling to maintain glucose homeostasis. As such alterations appear blunted by obesity; further investigation of weight-dependent effects of bile acid signalling on type 2 diabetes pathogenesis is warranted.https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24736330/?tool=EBI
collection DOAJ
language English
format Article
sources DOAJ
author David R Taylor
Jamshid Alaghband-Zadeh
Gemma F Cross
Sohail Omar
Carel W le Roux
Royce P Vincent
spellingShingle David R Taylor
Jamshid Alaghband-Zadeh
Gemma F Cross
Sohail Omar
Carel W le Roux
Royce P Vincent
Urine bile acids relate to glucose control in patients with type 2 diabetes mellitus and a body mass index below 30 kg/m2.
PLoS ONE
author_facet David R Taylor
Jamshid Alaghband-Zadeh
Gemma F Cross
Sohail Omar
Carel W le Roux
Royce P Vincent
author_sort David R Taylor
title Urine bile acids relate to glucose control in patients with type 2 diabetes mellitus and a body mass index below 30 kg/m2.
title_short Urine bile acids relate to glucose control in patients with type 2 diabetes mellitus and a body mass index below 30 kg/m2.
title_full Urine bile acids relate to glucose control in patients with type 2 diabetes mellitus and a body mass index below 30 kg/m2.
title_fullStr Urine bile acids relate to glucose control in patients with type 2 diabetes mellitus and a body mass index below 30 kg/m2.
title_full_unstemmed Urine bile acids relate to glucose control in patients with type 2 diabetes mellitus and a body mass index below 30 kg/m2.
title_sort urine bile acids relate to glucose control in patients with type 2 diabetes mellitus and a body mass index below 30 kg/m2.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2014-01-01
description Bile acids are important endocrine signalling molecules, modulating glucose homeostasis through activation of cell surface and nuclear receptors. Bile acid metabolism is altered in type 2 diabetes mellitus; however, whether this is of pathogenic consequence is not fully established. In this study urinary bile acid excretion in individuals with type 2 diabetes and matched healthy volunteers was assessed. Urinary bile acid excretion in type 2 diabetes patients was considered in the context of prevailing glycaemia and the patient body mass index. Urine bile acids were measured by liquid chromatography-tandem mass spectrometry, allowing individual quantification of 15 bile acid species. Urinary bile acid excretion in patients with type 2 diabetes who were normal weight (BMI 18.5-24.9 kg/m2) and overweight (BMI 25-29.9 kg/m2) were elevated compared to healthy normal weight volunteers, both p<0.0001. In obese (BMI ≥ 30 kg/m2) type 2 diabetes patients, urinary bile acid excretion was significantly lower than in the normal and overweight type 2 diabetes groups (both p<0.01). Total bile acid excretion positively correlated with HbA1c in normal (rs=0.85, p=<0.001) and overweight (rs=0.61, p=0.02) but not obese type 2 diabetes patients (rs=-0.08, p=0.73). The glycaemia-associated increases in urine bile acid excretion in normal weight and overweight type 2 diabetes seen in this study may represent compensatory increases in bile acid signalling to maintain glucose homeostasis. As such alterations appear blunted by obesity; further investigation of weight-dependent effects of bile acid signalling on type 2 diabetes pathogenesis is warranted.
url https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24736330/?tool=EBI
work_keys_str_mv AT davidrtaylor urinebileacidsrelatetoglucosecontrolinpatientswithtype2diabetesmellitusandabodymassindexbelow30kgm2
AT jamshidalaghbandzadeh urinebileacidsrelatetoglucosecontrolinpatientswithtype2diabetesmellitusandabodymassindexbelow30kgm2
AT gemmafcross urinebileacidsrelatetoglucosecontrolinpatientswithtype2diabetesmellitusandabodymassindexbelow30kgm2
AT sohailomar urinebileacidsrelatetoglucosecontrolinpatientswithtype2diabetesmellitusandabodymassindexbelow30kgm2
AT carelwleroux urinebileacidsrelatetoglucosecontrolinpatientswithtype2diabetesmellitusandabodymassindexbelow30kgm2
AT roycepvincent urinebileacidsrelatetoglucosecontrolinpatientswithtype2diabetesmellitusandabodymassindexbelow30kgm2
_version_ 1714823392555696128